AUNA · Auna S.A.

// // LUXEMBOURG--(BUSINESS WIRE)-- Auna S.A. (NYSE: AUNA) (“Auna” or “the Company”), a leading Latin American healthcare services and plan provider with operations in Mexico, Peru and Colombia, announced today the reporting dates for its Second Quarter 2026 financial results. Earnings Release Tuesday, August 18, 2026 Time: After Market Close Conference Call Wednesday, August 19, 2026 Time: 8:00 a.m. ET Quiet Period Monday, August 3 through Tuesday August 18, 2026 To participate, please dial +1 888 596 4144 (Toll-Free) +1 646 968 2525 (International) Entry Passcode: 3884034 Webcast: click here About Auna Auna is a leading horizontally and vertically integrated healthcare platform in Latin America with operations in Mexico, Peru, and Colombia, focusing on high-complexity diseases. Our mission is to transform healthcare by providing access to a highly integrated healthcare offering in the underpenetrated markets of Spanish-speaking Americas. Founded in 1989, Auna has built one of Latin America′s largest modern healthcare platforms that consists of a horizontally integrated network of healthcare facilities and a vertically integrated portfolio of oncological plans and selected general healthcare plans. As of June 30, 2026, Auna’s network included 31 healthcare facilities hospitals, ambulatory centers, and prevention and wellness centers with a total of 2,337 beds and 1.4 million health plan members. For more information visit www.aunainvestors.com Investor Relations Contact [email protected] Source: Auna S.A.

Auna S.A. (NYSE: AUNA) (“Auna” or “the Company”), a leading Latin American healthcare services and plan provider with operations in Mexico, Peru and Colombia, announced today the reporting dates for its Second Quarter 2026 financial results. Earnings Release Tuesday, August 18, 2026 Time: After Market Close Conference Call Wednesday, August 19, 2026 Time: 8:00 a.m. ET Quiet Period Monday, August 3 through Tuesday August 18, 2026 To participate, please dial +1 888 596 4144 (Toll-Free) +1 646 968 2525 (International) Entry Passcode: 3884034 Webcast: click here About Auna Auna is a leading horizontally and vertically integrated healthcare platform in Latin America with operations in Mexico, Peru, and Colombia, focusing on high-complexity diseases. Our mission is to transform healthcare by providing access to a highly integrated healthcare offering in the underpenetrated markets of Spanish-speaking Americas. Founded in 1989, Auna has built one of Latin America′s largest modern healthcare

// // LUXEMBOURG--(BUSINESS WIRE)-- Auna S.A. (“Auna” or the “Company”), a leading healthcare services platform in Latin America with operations in Mexico, Peru, and Colombia, today reported select operating metrics for the Second Quarter ended June 30, 2026. The Company publishes these key performance indicators on a quarterly basis as part of its commitment to providing investors with more information and a clearer understanding of Auna. Preliminary Key Performance Indicators As of second quarter ended June 30, 2026 Healthcare Services Mexico Key Operating Metrics 2Q'25 3Q'25 4Q'25 1Q'26 2Q'26 Emergency treatments (1) # 8,170 7,274 8,002 7,864 7,892 Surgeries (2) # 4,904 5,177 5,028 4,855 5,193 Total number of days hospitalized (3) # 24,791 25,450 24,156 25,122 25,169 Total Capacity Utilization (4) % 38.5% 39.1% 37.1% 39.4% 39.1% Chemotherapies & Radiotherapies (sessions) (5) # 2,690 3,678 3,983 4,162 4,994 Healthcare Services Peru Key Operating Metrics 2Q'25 3Q'25 4Q'25 1Q'26 2Q'26 Emergency treatments (1) # 47,602 49,049 47,885 45,485 51,769 Surgeries (2) # 5,438 5,034 4,973 5,851 5,552 Total number of days hospitalized (3) # 25,789 26,912 26,486 26,428 28,395 Total Capacity Utilization (4) % 73.6% 76.0% 74.8% 75.5% 80.2% Chemotherapies & Radiotherapies (sessions) (5) # 13,431 11,622 12,909 13,371 12,957 OncoSalud Peru Key Operating Metrics 2Q'25 3Q'25 4Q'25 1Q'26 2Q'26 Plan Memberships (6) # 1,388,579 1,395,509 1,424,695 1,439,781 1,472,019 Healthcare Services Colombia Key Operating Metrics 2Q'25 3Q'25 4Q'25 1Q'26 2Q'26 Emergency treatments (1) # 36,052 37,323 35,289 38,077 38,196 Surgeries (2) # 10,484 11,209 10,443 10,904 11,167 Total number of days hospitalized (3) # 78,583 80,176 79,349 80,716 81,558 Total Capacity Utilization (4) % 76.4% 77.1% 76.3% 79.3% 79.2% Protected lives (7) # 2,491,218 3,027,499 3,036,335 3,057,763 3,143,694 Chemotherapies & Radiotherapies (sessions) (5) # 33,912 36,668 35,941 36,619 39,628 1) Emergency care includes the number of visits to the emergency rooms and may include several visits per patient. 2) Number of surgeries includes inpatient surgeries, outpatient surgeries and cesarean sections. 3) Total number of days during which any of Auna's beds were occupied by a hospitalized patient during the period, including ICU. 4) Total capacity utilization is calculated as (i) (x) total number of days in which any of Auna's beds had a hospitalized patient during the period divided by (y) total number of beds, times (ii) total number of days during the period. 5) Intravenous chemotherapy and radiotherapy infusions in both inpatient and outpatient care; excludes oral treatments. In Peru, includes sessions across the Healthcare Services Network and OncoSalud Segments. 6) As of period end and as reported to the National Superintendence of Health Susalud in Peru. 7) Insured population assigned to Auna under risk-sharing agreements in Colombia. About Auna Auna is one of Latin America’s leading healthcare platforms, with operations in Mexico, Peru, and Colombia. It prioritizes prevention and focuses on complex diseases that represent the highest healthcare spending. Its mission is to transform healthcare by delivering access to a highly integrated offering of services in low-penetration markets across Spanish-speaking Latin America. Founded in 1989, Auna has built one of the region’s largest modern healthcare platforms, consisting of a horizontally integrated network of medical care centers and a vertically integrated portfolio of oncology and general health plans. As of June 30, 2026, Auna’s network included 31 healthcare facilities—hospitals, ambulatory centers, and prevention and wellness centers—with a total of 2,337 beds and 1.4 million health plan members. Preliminary Information The information contained in this press release is preliminary in nature and is provided for informational purposes only. It is based on current estimates, assumptions, and expectations, which remain subject to ongoing

Auna S.A. (“Auna” or the “Company”), a leading healthcare services platform in Latin America with operations in Mexico, Peru, and Colombia, today reported select operating metrics for the Second Quarter ended June 30, 2026. The Company publishes these key performance indicators on a quarterly basis as part of its commitment to providing investors with more information and a clearer understanding of Auna. Preliminary Key Performance Indicators As of second quarter ended June 30, 2026 Healthcare Services Mexico Key Operating Metrics 2Q'25 3Q'25 4Q'25 1Q'26 2Q'26 Emergency treatments (1) # 8,170 7,274 8,002 7,864 7,892 Surgeries (2) # 4,904 5,177 5,028 4,855 5,193 Total number of days hospitalized (3) # 24,791 25,450 24,156 25,122 25,169 Total Capacity Utilization (4) % 38.5% 39.1% 37.1% 39.4% 39.1% Chemotherapies & Radiotherapies (sessions) (5) # 2,690 3,678 3,983 4,162 4,994 Healthcare Services Peru Key Operating Metrics 2Q'25 3Q'25 4Q'25 1Q'26 2Q'26 Emergency treatments (1) #

// // Strong top-line growth and cash flow performance; Consolidated Adjusted EBITDA impacted by revenue adjustments; Mexico volumes and revenues growing rapidly, with Segment Adjusted EBITDA increasing 19% QoQ LUXEMBOURG--(BUSINESS WIRE)-- Auna (NYSE: AUNA) (“Auna” or the “Company”) , a leading healthcare platform in Latin America with operations in Mexico, Peru, and Colombia, announced today financial results for the first quarter ended March 31, 2026 (“first quarter 2026” or “1Q26”). Financial results are expressed in Peruvian Soles (“S/” or “PEN” or “Soles”) and are presented in accordance with International Financial Reporting Standards (“IFRS”), unless otherwise noted. 1Q’26 Consolidated Highlights Revenue increased 10% FXN, or 13% YoY on a reported basis, to S/1,178 million Mexico Revenue increased 15% YoY on a reported basis, to S/ 279 million Adjusted EBITDA was S/217 million, a decrease of 2% YoY Adjusted EBITDA Margin of 18.4%, down 2.9 p.p. YoY from 21.4% in 1Q25 Operating Cash Flow and Free Cash Flow increased 48% YoY and 2.6x YoY, respectively Leverage Ratio was stable at 3.7x Oncology MLR decreased 2.0 p.p. YoY to 49.6% Number of surgeries increased 4.4% YoY to 21,610 Number of days hospitalized increased 2.9% YoY to 132,266 Message from Auna’s Executive Chairman and President Auna began 2026 with strong commercial momentum across all three of our markets. First quarter revenues grew 10% FXN, reflecting the impact of the strategic and structural decisions implemented throughout 2025 and further validating the strength of our integrated platform. The AunaWay model continues driving sustainable growth across our markets, with positive underlying operating trends, despite short-term Adjusted EBITDA impacts in Peru and Mexico. In Peru, our integrated healthcare model continued to perform well at scale, delivering solid top-line growth of 9% in local currency, with strong volume increases across hospitals, emergency services, and oncology. Oncosalud maintained its growth trajectory, adding new members and securing a group policy for the nation’s judiciary — a new and prestigious institutional relationship representing nearly 20,000 lives, and contributing to a total of 1.4 million Oncosalud members. While the underlying business dynamic and margin contributions remain stable in Peru, Adjusted EBITDA was impacted in the healthcare services business by delays in pharmacy rebates and revenue adjustments related to certain payors. Oncosalud's MLR of 49.6% in the quarter is consistent with our pricing and MLR management discipline. In Mexico, our healthcare network continues showing strong signs of recovery and our oncology and high-complexity footprint is growing. Sequential Adjusted EBITDA increased 19% from 4Q25 and margins improved 3.5 p.p. The healthcare network delivered 8% year-over-year revenue growth in local currency and the Monterrey operational initiatives gained further traction. Patient volumes increased 13% quarter-over-quarter, as our growing relationships with payors and our commitment to contain costs for them, while improving patient experiences and medical resolutions are producing higher revenues across service lines. Our oncology business grew 32% from 4Q25 representing 11% of Mexico network revenues, up from 4% one year ago. These trends reflect the impact of the growth initiatives implemented under our new Monterrey leadership team and are delivering clear results. In Colombia, reven

Strong top-line growth and cash flow performance; Consolidated Adjusted EBITDA impacted by revenue adjustments; Mexico volumes and revenues growing rapidly, with Segment Adjusted EBITDA increasing 19% QoQ Auna (NYSE: AUNA) (“Auna” or the “Company”) , a leading healthcare platform in Latin America with operations in Mexico, Peru, and Colombia, announced today financial results for the first quarter ended March 31, 2026 (“first quarter 2026” or “1Q26”). Financial results are expressed in Peruvian Soles (“S/” or “PEN” or “Soles”) and are presented in accordance with International Financial Reporting Standards (“IFRS”), unless otherwise noted. 1Q’26 Consolidated Highlights Revenue increased 10% FXN, or 13% YoY on a reported basis, to S/1,178 million Mexico Revenue increased 15% YoY on a reported basis, to S/ 279 million Adjusted EBITDA was S/217 million, a decrease of 2% YoY Adjusted EBITDA Margin of 18.4%, down 2.9 p.p. YoY from 21.4% in 1Q25 Operating Cash Flow and Free Cash Flow

// // LUXEMBOURG--(BUSINESS WIRE)-- Auna S.A. (“Auna” or the “Company”) (NYSE: AUNA) , a Latin American healthcare company with operations in Mexico, Peru and Colombia, announced today the filing of its Annual Report on Form 20-F for the fiscal year ended December 31, 2025, with the Securities and Exchange Commission (the “SEC”) on April, 21, 2026. Auna’s Annual Report on Form 20-F can be accessed by visiting either the SEC’s website at www.sec.gov or the “Financial Info” section of the Company’s Investor Relations website at www.aunainvestors.com . In addition, shareholders may receive a hard copy of the Company’s audited financial statements, or its complete 2025 Form 20-F including audited financial statements, free of charge, by requesting a copy from the Investor Relations team at [email protected] About Auna Auna is one of Latin America’s leading healthcare platforms, with operations in Mexico, Peru, and Colombia. It prioritizes prevention and focuses on complex diseases that represent the highest healthcare spending. Its mission is to transform healthcare by delivering access to a highly integrated offering of services in low-penetration markets across Spanish-speaking Latin America. Founded in 1989, Auna has built one of the region’s largest modern healthcare platforms, consisting of a horizontally integrated network of medical care centers and a vertically integrated portfolio of oncology and general health plans. As of March 31, 2026, Auna’s network included 31 healthcare facilities—hospitals, ambulatory centers, and prevention and wellness centers—with a total of 2,333 beds and 1.4 million health plan members. For more information visit www.aunainvestors.com Investor Relations Contact [email protected] Source: Auna S.A.

Auna S.A. (“Auna” or the “Company”) (NYSE: AUNA) , a Latin American healthcare company with operations in Mexico, Peru and Colombia, announced today the filing of its Annual Report on Form 20-F for the fiscal year ended December 31, 2025, with the Securities and Exchange Commission (the “SEC”) on April, 21, 2026. Auna’s Annual Report on Form 20-F can be accessed by visiting either the SEC’s website at www.sec.gov or the “Financial Info” section of the Company’s Investor Relations website at www.aunainvestors.com . In addition, shareholders may receive a hard copy of the Company’s audited financial statements, or its complete 2025 Form 20-F including audited financial statements, free of charge, by requesting a copy from the Investor Relations team at [email protected] About Auna Auna is one of Latin America’s leading healthcare platforms, with operations in Mexico, Peru, and Colombia. It prioritizes prevention and focuses on complex diseases that represent the highest

// // LUXEMBOURG--(BUSINESS WIRE)-- Auna S.A. (NYSE: AUNA) (“Auna” or the “Company”), a leading healthcare services platform in Latin America with operations in Mexico, Peru, and Colombia, today reported select operating metrics for the First Quarter ended March 31, 2026. The Company intends to publish these key performance indicators on a quarterly basis going forward, as part of its commitment to providing investors with more information and a clearer understanding of Auna. Preliminary Key Performance Indicators As of first quarter ended March 31, 2026 Healthcare Services Mexico Key Operating Metrics <td class="bwalignr bwvertalignm bwpadl0 bwwidth1" co

Auna S.A. (NYSE: AUNA) (“Auna” or the “Company”), a leading healthcare services platform in Latin America with operations in Mexico, Peru, and Colombia, today reported select operating metrics for the First Quarter ended March 31, 2026. The Company intends to publish these key performance indicators on a quarterly basis going forward, as part of its commitment to providing investors with more information and a clearer understanding of Auna. Preliminary Key Performance Indicators As of first quarter ended March 31, 2026 Healthcare Services Mexico Key Operating Metrics 1Q'25 2Q'25 3Q'25 4Q'25 1Q'26 Emergency treatments (1) # (000) 8,053 8,170 7,274 8,002 7,864 Surgeries (2) # (000) 4,687 4,904 5,177 5,028 4,855 Total number of days hospitalized (3) # 25,344 24,791 25,450 24,156 25,122 Total Capacity Utilization (4) % 39.8% 38.5% 39.1% 37.1% 39.4% Chemotherapies & Radiotherapies (sessions) (5) # 2,333 <

// // LUXEMBOURG--(BUSINESS WIRE)-- Auna S.A. (NYSE: AUNA) (“Auna” or “the Company”), a leading Latin American healthcare services and plan provider with operations in Mexico, Peru and Colombia, announced today the reporting dates for its First Quarter 2026 financial results. Earnings Release Tuesday, May 19, 2026 Time: After Market Close Conference Call Wednesday, May 20, 2026 Time: 8:00 a.m. ET Quiet Period Monday, May 4 through Tuesday May 19, 2026 To participate, please dial +1 888 596 4144 (Toll-Free) +1 646 968 2525 (International) Entry Passcode: 3884034 Webcast: click here About Auna Auna is a leading horizontally and vertically integrated healthcare platform in Latin America with operations in Mexico, Peru, and Colombia, focusing on high-complexity diseases. Our mission is to transform healthcare by providing access to a highly integrated healthcare offering in the underpenetrated markets of Spanish-speaking Americas. Founded in 1989, Auna has built one of Latin America′s largest modern healthcare platforms that consists of a horizontally integrated network of healthcare facilities and a vertically integrated portfolio of oncological plans and selected general healthcare plans. As of December 31, 2025, Auna’s network included 31 healthcare network facilities, including hospitals, outpatient, prevention and wellness facilities with 2,333 beds, and 1.4 million healthcare plans. For more information visit www.aunainvestors.com Investor Relations Contact [email protected] Source: Auna S.A.

Auna S.A. (NYSE: AUNA) (“Auna” or “the Company”), a leading Latin American healthcare services and plan provider with operations in Mexico, Peru and Colombia, announced today the reporting dates for its First Quarter 2026 financial results. Earnings Release Tuesday, May 19, 2026 Time: After Market Close Conference Call Wednesday, May 20, 2026 Time: 8:00 a.m. ET Quiet Period Monday, May 4 through Tuesday May 19, 2026 To participate, please dial +1 888 596 4144 (Toll-Free) +1 646 968 2525 (International) Entry Passcode: 3884034 Webcast: click here About Auna Auna is a leading horizontally and vertically integrated healthcare platform in Latin America with operations in Mexico, Peru, and Colombia, focusing on high-complexity diseases. Our mission is to transform healthcare by providing access to a highly integrated healthcare offering in the underpenetrated markets of Spanish-speaking Americas. Founded in 1989, Auna has built one of Latin America′s largest modern healthcare platforms

// // Auna Closes FY 2025 with Strong Performance in Peru and Colombia and 35% increase in Free Cash Flow Signs of Recovery in Mexico in 2026 Company Sets 12% Adjusted EBITDA Growth Guidance for 2026 LUXEMBOURG--(BUSINESS WIRE)-- Auna (NYSE: AUNA) (“Auna” or the “Company”) , a leading healthcare platform in Latin America with operations in Mexico, Peru, and Colombia, announced today financial results for the fourth quarter ended December 31, 2025 (“fourth quarter 2025” or “4Q25”) and full-year ended 2025 (“full-year 2025” or “FY25”). Financial results are expressed in Peruvian Soles (“S/” or “PEN”) and are presented in accordance with International Financial Reporting Standards (“IFRS”), unless otherwise noted. FY25 Consolidated Highlights Revenue increased 4% FXN to S/4,385 million, and was flat on reported basis Adjusted EBITDA decreased 3% FXN, or 8% YoY on reported basis, to S/917 million Adjusted EBITDA Margin of 20.9%, down 1.7 p.p. YoY from 22.6% in FY24 Operating Cash Flow and Free Cash Flow increased 2% YoY and 35% YoY, respectively Adjusted Net Income was S/336 million, up from S/146 million in FY24 Oncology MLR decreased to record 48.5% since 2022, down from 53.0% in FY24 4Q25 Consolidated Highlights Revenue increased 6% FXN, or 7% YoY on reported basis, to S/1,133 million Adjusted EBITDA was S/220 million, a decrease of 14% FXN, or 13% YoY Adjusted EBITDA Margin of 19.5%, down 4.5 p.p. YoY from 23.9% in 4Q24 Adjusted Net Income of S/136 million, up from S/36 million in 4Q24 Leverage Ratio remained unchanged at 3.6x Message from Auna’s Executive Chairman and President Auna closed fiscal year 2025 with resilient performance. Peru and Colombia delivered in line with our expectations, while consolidated performance reflected challenges in Mexico. Results in the fourth quarter of 2025 and the first two months of 2026 indicate a clear stabilization and recovery of the Mexico operations, which are now on track to deliver sustained top-line and EBITDA growth in 2026. Under the leadership of our new management team in Mexico, we have focused on expanding our reach into the larger segments of privately insured families and further strengthening our alignment with physician groups. While these initiatives were implemented late in the year and did not offset the volume losses experienced earlier in 2025, they have strengthened the foundation of the Mexico platform and position the business to return to sustainable organic growth in 2026. In Peru, where our integrated healthcare model continues to perform at scale, we delivered solid and predictable results. The consolidated integrated network and the healthcare delivery network increased revenues by 11% and Adjusted EBITDA by 14%. In oncology, the MLR improved to a record low of 48.5%, reflecting disciplined pricing execution and continued efficiency in care management. Peru’s growth profile has been strengthened with the authorization to commence the refurbishment, completion and opening of Centro Ambulatorio Trecca in Lima in 2028, an ambulatory facility that we expect will expand our addressable market and transform how we will serve up to 3 million EsSalud beneficiaries annually. In Mexico, where we are focused on recapturing and accelerating our growth and profitability initiatives, 4Q25 and the first two months of 2026 showed strong signs of recovery. Our decision to adjust the leadership team in Monterrey, bringing d

Auna Closes FY 2025 with Strong Performance in Peru and Colombia and 35% increase in Free Cash Flow Signs of Recovery in Mexico in 2026 Company Sets 12% Adjusted EBITDA Growth Guidance for 2026 Auna (NYSE: AUNA) (“Auna” or the “Company”) , a leading healthcare platform in Latin America with operations in Mexico, Peru, and Colombia, announced today financial results for the fourth quarter ended December 31, 2025 (“fourth quarter 2025” or “4Q25”) and full-year ended 2025 (“full-year 2025” or “FY25”). Financial results are expressed in Peruvian Soles (“S/” or “PEN”) and are presented in accordance with International Financial Reporting Standards (“IFRS”), unless otherwise noted. FY25 Consolidated Highlights Revenue increased 4% FXN to S/4,385 million, and was flat on reported basis Adjusted EBITDA decreased 3% FXN, or 8% YoY on reported basis, to S/917 million Adjusted EBITDA Margin of 20.9%, down 1.7 p.p. YoY from 22.6% in FY24 Operating Cash Flow and Free Cash Flow

// // LUXEMBOURG--(BUSINESS WIRE)-- Auna S.A. (“Auna” or the “Company”), a leading healthcare services platform in Latin America with operations in Mexico, Peru, and Colombia, today announced the formal execution of an addendum to its existing Public-Private Partnership (“PPP”) agreement with EsSalud, Peru’s Social Health Insurance agency. This agreement facilitates the commencement of the construction phase of the Torre Trecca project in Lima. The execution of the addendum is an important milestone for the project and formally authorizes the commencement of construction of Torre Trecca, a 23-story, high-complexity outpatient healthcare facility. The facility will encompass approximately 59,000 square meters of built area, 145 consultation offices, and 43 treatment rooms. Upon its completion, Torre Trecca is expected to expand EsSalud’s healthcare capacity in metropolitan Lima by approximately 20%. Furthermore, it will substantially reduce waiting times for more than six million insured Peruvians, with the capacity to support over three million patient visits annually. The PPP will establish an obligation to provide an increasing number of outpatient services to EsSalud’s population at Torre Trecca. The initial year of operation is anticipated to commence in mid-2028 with 600,000 patient services, which are expected to expand annually until the PPP’s termination in 2046, although it can be renewed and extended to 2064. The facility will offer a comprehensive range of outpatient and diagnostic service packages, encompassing ambulatory care packages, preventive care programs, specialized procedures, ambulatory emergency services, surgical risk assessment packages, and advanced imaging services, including diagnostic interpretation and MRI procedures. Suso Zamora, President and Executive Chairman of the Board of Auna, stated, “The signing of this addendum is a significant milestone for Auna and for the modernization of public healthcare delivery in Peru. It fully aligns with our AunaWay strategy to expand access to high-quality, sustainable healthcare throughout Latin America. Serving EsSalud, the largest payor and provider in Peru - one that grants healthcare coverage to most public and private employees, independent professionals, and retirees, along with their dependent family members - significantly expands our addressable market in the country.” Mr. Zamora further underscored that, “Serving this substantial demographic segment is a pivotal opportunity. Our unwavering dedication to redefining healthcare delivery and plans has placed Auna in a unique position to seize this moment and generate value for all stakeholders.” Luis Felipe Pinillos, Vice Chairman of the Board of Auna, stated: “Torre Trecca is a strategic priority for EsSalud and ProInversion as they seek to close the healthcare access gap in metropolitan Lima through modern infrastructure, advanced technology, and greater efficiency. This partnership with Auna will expand specialized outpatient and diagnostic capacity and represents a meaningful step forward in their mission to deliver timely, high-quality healthcare to the insured population.” The Torre Trecca project is structured under a concession framework and implemented through a dedicated project vehicle, with financing, assets and cash flow at the project level, and provides for an initial 20-year term, renewable for an additional 18 years. The contractual design segregates construction risk from operational risk through distinct payment mechanisms and ring-fenced cash flows. Under the PPP framework, once the facility is operational, EsSalud will provide a guaranteed minimum monthly payment through the issuance of certificates, which will cover fi

Auna S.A. (“Auna” or the “Company”), a leading healthcare services platform in Latin America with operations in Mexico, Peru, and Colombia, today announced the formal execution of an addendum to its existing Public-Private Partnership (“PPP”) agreement with EsSalud, Peru’s Social Health Insurance agency. This agreement facilitates the commencement of the construction phase of the Torre Trecca project in Lima. The execution of the addendum is an important milestone for the project and formally authorizes the commencement of construction of Torre Trecca, a 23-story, high-complexity outpatient healthcare facility. The facility will encompass approximately 59,000 square meters of built area, 145 consultation offices, and 43 treatment rooms. Upon its completion, Torre Trecca is expected to expand EsSalud’s healthcare capacity in metropolitan Lima by approximately 20%. Furthermore, it will substantially reduce waiting times for more than six million insured Peruvians, with the capacity to

// // LUXEMBOURG--(BUSINESS WIRE)-- Auna S.A. (NYSE: AUNA) (“Auna” or “the Company”), a leading Latin American healthcare services and plan provider with operations in Mexico, Peru and Colombia, announced today the reporting dates for its Fourth Quarter and Full-Year 2025 financial results. Earnings Release Tuesday, March 10, 2026 Time: After Market Close Conference Call Wednesday, March 11, 2026 Time: 8:00 a.m. ET Quiet Period Monday, February 23 through Tuesday, March 10, 2026 To participate, please dial +1 888 596 4144 (Toll-Free) +1 646 968 2525 (International) Entry Passcode: 3884034 Webcast: click here About Auna Auna is a leading horizontally and vertically integrated healthcare platform in Latin America with operations in Mexico, Peru, and Colombia, focusing on high-complexity diseases. Our mission is to transform healthcare by providing access to a highly integrated healthcare offering in the underpenetrated markets of Spanish-speaking Americas. Founded in 1989, Auna has built one of Latin America′s largest modern healthcare platforms that consists of a horizontally integrated network of healthcare facilities and a vertically integrated portfolio of oncological plans and selected general healthcare plans. As of September 30, 2025, Auna’s network included 31 healthcare network facilities, including hospitals, outpatient, prevention and wellness facilities with 2,333 beds, and 1.4 million healthcare plans. For more information visit www.aunainvestors.com Investor Relations Contact [email protected] Source: Auna S.A.

Auna S.A. (NYSE: AUNA) (“Auna” or “the Company”), a leading Latin American healthcare services and plan provider with operations in Mexico, Peru and Colombia, announced today the reporting dates for its Fourth Quarter and Full-Year 2025 financial results. Earnings Release Tuesday, March 10, 2026 Time: After Market Close Conference Call Wednesday, March 11, 2026 Time: 8:00 a.m. ET Quiet Period Monday, February 23 through Tuesday, March 10, 2026 To participate, please dial +1 888 596 4144 (Toll-Free) +1 646 968 2525 (International) Entry Passcode: 3884034 Webcast: click here About Auna Auna is a leading horizontally and vertically integrated healthcare platform in Latin America with operations in Mexico, Peru, and Colombia, focusing on high-complexity diseases. Our mission is to transform healthcare by providing access to a highly integrated healthcare offering in the underpenetrated markets of Spanish-speaking Americas. Founded in 1989, Auna has built one of Latin America′s largest

// // Auna Delivers Solid Financial and Operating Performance in Peru and Colombia, While Advancing Key Initiatives in Mexico LUXEMBOURG--(BUSINESS WIRE)-- Auna (NYSE: AUNA) (“Auna” or the “Company”) , a leading healthcare platform in Latin America with operations in Mexico, Peru, and Colombia, announced today financial results for the third quarter ended September 30, 2025 (“third quarter 2025” or “3Q25”). Financial results are expressed in Peruvian Soles (“S/” or PEN”) and are presented in accordance with International Financial Reporting Standards (“IFRS”), unless otherwise noted. 3Q25 Consolidated Highlights Consolidated Revenue increased 1% FXN, while decreasing 1% YoY on reported basis, to S/1,117 million Adjusted EBITDA decreased 5% FXN, or 7% YoY on reported basis, to S/232 million Adjusted EBITDA Margin of 20.8%, down 1.3 p.p. YoY from 22.1% Adjusted Net Income was S/58 million, down from S/75 million in 3Q24 Leverage Ratio remains unchanged at 3.6x Mexico’s surgeries and oncology services increased for the second consecutive quarter Oncology MLR decreased to 49.3% Message from Auna’s Executive Chairman and President Despite weaker financial yet promising operational results, the third quarter of 2025 demonstrates the enduring resilience of Auna’s integrated regional healthcare platform and the robust performance of our operations. The operations in Peru and Colombia achieved substantial growth and profitability in local currency, despite challenging macroeconomic conditions, while in our Mexico business, which is slowly recovering from previously communicated challenges, hospital operations remained stable, although the segment delivered less favorable financial results. In Peru, both Oncosalud and Healthcare Services delivered consistently strong performance levels, supported by growth in memberships, annual pricing adjustments, and the sustained improvement of the Oncology MLR to 49.3%. The disciplined containment of costs and the operational efficiency of our medical talent continued to underpin this performance. Our results were strong in Colombia, with double-digit growth in Adjusted EBITDA and continued expansion of risk-sharing Prospective Global Payment (“PGP”) models. The team's focus on reducing exposure to intervened payors and optimizing resource utilization supported profitability and improved cash generation. In Mexico, despite a second consecutive quarterly increase in the number of surgeries and growth in oncology and cardiology services, revenues and profitability declined year over year due to still lackluster demand for medical procedures, a sluggish recovery of volumes affected by legacy physician and supplier relationships, and migration issues related to the implementation of new Hospital Information and ERP systems at Doctors Hospital, which we expect to resolve in the coming months. At the consolidated level, our leverage remained stable at 3.6x Net Debt-to-Adjusted EBITDA, reflecting a disciplined approach to capital allocation, a robust cash position, and continued progress toward our medium-term deleveraging objective of below 3x. Additionally, following quarter-end, Auna completed a USD765 million debt refinancing that extends debt maturities, reduces interest costs, and further fortifies Auna’s capital structure. Complementing these efforts, the announcement of our partnership with Sojitz and the recent Trecca milestone underscore the confidence in our strategy in Mexico and the significant opportunities that remain in Peru, while a

// // LUXEMBOURG--(BUSINESS WIRE)-- Auna S.A. (“Auna” or the “Company”), a leading healthcare services provider in Latin America with operations in Mexico, Peru, and Colombia, announced today that Auna and Sojitz Corporation of America (“Sojitz”), a global investment and trading group headquartered in Japan, have entered into a Memorandum of Understanding (MOU) to explore joint business opportunities in the healthcare sector across Latin America, with an initial focus on Mexico, one of the region’s largest and fastest-growing healthcare markets. On September 24, 2025, Auna announced its intention to invest approximately US$500 million over the next three to five years to expand its integrated healthcare platform in Mexico. The collaboration seeks to combine Auna’s healthcare and operational expertise with Sojitz’s investment capabilities in healthcare and international network to accelerate the development of modern, scalable, and accessible healthcare infrastructure and services in Latin America. “We have had ongoing conversations with Sojitz over the years about joining forces, and this framework cements our shared vision. This agreement marks an important step in Auna’s strategy to expand our integrated care model and bring high-quality healthcare to more people in Mexico and across Latin America,” said Suso Zamora, Executive Chairman and President of Auna. “We are very pleased to collaborate with Auna, whose mission to expand access to high quality healthcare aligns closely with Sojitz’s commitment to building sustainable businesses that create long-term social value,” said Koichi Yamaguchi, President of Sojitz Corporation of America. About Auna Auna is one of Latin America’s leading healthcare platforms, with operations in Mexico, Peru, and Colombia. It prioritizes prevention and focuses on complex diseases that represent the highest healthcare spending. Its mission is to transform healthcare by delivering access to a highly integrated offering of services in low-penetration markets across Spanish-speaking Latin America. Founded in 1989, Auna has built one of the region’s largest modern healthcare platforms, consisting of a horizontally integrated network of medical care centers and a vertically integrated portfolio of oncology and general health plans. As of June 30, 2025, Auna’s network included 31 healthcare facilities—hospitals, ambulatory centers, and prevention and wellness centers—with a total of 2,333 beds and 1.4 million health plan members. Cautionary Statement on Forward-Looking Statements This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements often are proceeded by words such as “believes,” “expects,” “may,” “anticipates,” “plans,” “intends,” “assumes,” “will” or similar expressions. The forward-looking statements contained herein include statements about the Company’s collaboration with Sojitz and planned investments in Mexico. These expectations may or may not be realized. Some of these expectations may be based upon assumptions or judgments that prove to be incorrect. In addition, Auna’s business and operations involve numerous risks and uncertainties, many of which are beyond the control of Auna, which could result in Auna’s expectations not being realized or otherwise materially affect the financial condition, results of operations and cash flows of Auna. Some of the factors that could cause future results to materially differ from recent results or those projected in forward-looking statements are described in Auna’s filings with the United States Securities and Exchange

// // LUXEMBOURG--(BUSINESS WIRE)-- Auna S.A. (“Auna” or the “Company”), a leading healthcare services provider in Latin America with operations in Mexico, Peru, and Colombia, announced today that EsSalud, Peru’s Social Security System, has formally received the construction license for Torre Trecca, a high-rise outpatient treatment center that Auna will rebuild and, upon completion, operate on behalf of EsSalud as part of an existing public–private partnership (“PPP”). When completed, Torre Trecca is expected to serve more than six million Peruvians living in the city of Lima who are insured by EsSalud and to accommodate more than three million visits annually. The license milestone was commemorated during a ceremony attended by the Executive Director of ProInversión (the Peruvian government agency that promotes private investment), Luis Del Carpio; the Executive President of EsSalud, Segundo Acho Mego; the Mayor of the Jesús María District, Jesús Gálvez, and the Vice Chairman of Auna, Luis Felipe Pinillos. Auna first entered into the PPP with EsSalud in 2010 to rebuild Torre Trecca and operate the facility on behalf of the institution. The approval and formal delivery of the construction license to EsSalud represents an important step toward upgrading and modernizing this high-impact healthcare project. The amendment to the Torre Trecca PPP contract awarded to Auna is expected to receive final approval by the end of this year, enabling construction to begin in 2026. Auna reaffirmed its commitment to expanding access to high-quality healthcare services for the people of Lima. This significant milestone in the advancement of the PPP underscores the substantial progress achieved through the close collaboration of EsSalud and ProInversión. About Auna Auna is one of Latin America’s leading healthcare platforms, with operations in Mexico, Peru, and Colombia. It prioritizes prevention and focuses on complex diseases that represent the highest healthcare spending. Its mission is to transform healthcare by delivering access to a highly integrated offering of services in low-penetration markets across Spanish-speaking Latin America. Founded in 1989, Auna has built one of the region’s largest modern healthcare platforms, consisting of a horizontally integrated network of medical care centers and a vertically integrated portfolio of oncology and general health plans. As of June 30, 2025, Auna’s network included 31 healthcare facilities—hospitals, ambulatory centers, and prevention and wellness centers—with a total of 2,333 beds and 1.4 million health plan members. Cautionary Statement on Forward-Looking Statements This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements often are proceeded by words such as “believes,” “expects,” “may,” “anticipates,” “plans,” “intends,” “assumes,” “will” or similar expressions. The forward-looking statements contained herein include statements about the expected final approval and beginning of construction of Torre Trecca in 2026 and the expected capacity and market of Torre Trecca once built. These expectations may or may not be realized. Some of these expectations may be based upon assumptions or judgments that prove to be incorrect. In addition, Auna’s business and operations involve numerous risks and uncertainties, many of which are beyond the control of Auna, which could result in Auna’s expectations not being realized or otherwise materially affect the financial condition, results of operations and cash flows of Auna. Some of the factors that could cause future results to mate